Gazette.govt.nzPursuant to clause 8 of the COVID-19 Public Health Response (Point-of-care Tests) Order 2021 (“Order”), I, as the Director-General of Health, hereby specify the following persons or class of persons to import, supply and sell point-of-care tests for COVID-19 for the purposes of clause 8 of the Order:
| Name of Company | New Zealand Business Number |
| Roche Diagnostics NZ Ltd | 9429039820518 |
| Abbott Rapid Diagnostics | 9429032718850 |
| Pantonic Health (Australia) or Arrotex Pharmaceuticals (NZ) Limited | 9429041542033 |
| EBOS Group Ltd | 94290319988404 |
| Ministry of Health | 9429000082440 |
Pursuant to clause 8 of the COVID-19 Public Health Response (Point-of-care Tests) Order 2021 (“Order”), I, as the Director-General of Health, hereby specify the following persons or class of persons to use point-of-care tests for COVID-19 for the purposes of clause 8 of the Order:
- All laboratories accredited by International Accreditation New Zealand (IANZ) to ISO 15189 for COVID-19 testing, and providing laboratory testing services to District Health Boards.
- All NZ District Health Board hospitals.
- New Zealand Medical Assistance Team (NZMAT).
- All signatory businesses to the Ministry of Business, Innovation and Employment Business Charter.
- New Zealand Police.
- Department of Corrections.
Pursuant to clause 9 of the COVID-19 Public Health Response (Point-of-care Tests) Order 2021 (“Order”), I, as the Director-General of Health, hereby specify the following point-of-care tests or class of point-of-care tests that are exempt from clause 7(b) of the Order:
| Product Name | Manufacturer | Product Code |
| SARS-CoV-2 Rapid Antigen Test (SD Biosensor) (Nasal) | SD Biosensor (South Korea) | 09365397043 |
| PanBio COVID-19 Ag Rapid (Nasal) | Abbott Rapid Diagnostics Jena GmbH (Germany) | 41FK11 |
| CareStart COVID-19 Antigen (Nasal) | Access Bio Inc (United States of America) | 7006576 |
Dated this 10th day of November 2021.
Dr ASHLEY BLOOMFIELD, Director-General of Health.